Julie Devin
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Synthetic Lethal Combinations of DNA Repair Inhibitors and Genotoxic Agents to Target High-Risk Diffuse Large B Cell Lymphoma.
Journal: Hematological oncology
Published: April 14, 2025
Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth.
Journal: eLife
Published: January 31, 2025
Ironomycin induces mantle cell lymphoma cell death by targeting iron metabolism addiction.
Journal: Theranostics
Published: August 02, 2024
High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.
Journal: Physical review letters
Published: June 15, 2024
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance.
Journal: Frontiers in immunology
Published: June 30, 2022
Search for Dark Matter Annihilation Signals in the H.E.S.S. Inner Galaxy Survey.
Journal: Physical review letters
Published: October 11, 2021
PIM2 kinase has a pivotal role in plasmablast generation and plasma cell survival, opening up novel treatment options in myeloma.
Journal: Blood
Published: September 07, 2021
Targeting Cellular Iron Homeostasis with Ironomycin in Diffuse Large B-cell Lymphoma.
Journal: Cancer research
Published: January 20, 2021
Revealing x-ray and gamma ray temporal and spectral similarities in the GRB 190829A afterglow.
Journal: Science (New York, N.Y.)
Published: September 18, 2020
Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact.
Journal: Journal of clinical medicine
Published: June 19, 2019
Last Updated: 09/26/2026